Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02840799 · ClinicalTrials.gov registry record · Phase 2
Effect of KNO3 Compared to KCl on Oxygen UpTake in Heart Failure With Preserved Ejection Fraction (KNO3CK OUT HFPEF)
A Phase 2 study, sponsored by University of Pennsylvania.
- Completed
- Registry status
- Phase 2
- Development phase
- 84
- Enrollment target
NCT02840799: Completed Phase 2 study, sponsored by University of Pennsylvania.
NCT02840799 is a Phase 2 study that has completed, run by University of Pennsylvania. The registered enrollment target is 84 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02840799, a Phase 2 study, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 84 participants
- Enrollment target
Study Summary
This trial seeks to assess if potassium nitrate (KNO3) therapy improves exercise capacity and oxygen uptake in heart failure patients with preserved ejection fraction (HFpEF).
Interventions
- DRUG Potassium Chloride (KCl)
- DRUG Potassium Nitrate (KNO3)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 84 participants |
| Start Date | 2016-08 |
| Est. Completion | 2022-08 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02840799
The ClinicalTrials.gov registry entry for NCT02840799 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 84 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Potassium Chloride (KCl) is the first listed.
NCT02840799 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02840799 about?
NCT02840799 is a clinical study titled "Effect of KNO3 Compared to KCl on Oxygen UpTake in Heart Failure With Preserved Ejection Fraction (KNO3CK OUT HFPEF)". This trial seeks to assess if potassium nitrate (KNO3) therapy improves exercise capacity and oxygen uptake in heart failure patients with preserved ejection fraction (HFpEF).
What is the current status of trial NCT02840799?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 84 participants. The study started on 2016-08. Estimated completion is 2022-08.
What interventions are being tested in trial NCT02840799?
The interventions under investigation include: Potassium Chloride (KCl) (DRUG), Potassium Nitrate (KNO3) (DRUG).
Who is sponsoring clinical trial NCT02840799?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.